Clinical Trial Update: Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating Yangxinshi Pills for improving exercise tolerance in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Yangxinshi Pills

Snippet

Sponsor: Affiliated Hospital of Changchun University of Chinese Medicine | Conditions: Coronary Heart Disease | Phase 2 | Status: UNKNOWN